Zimmer Biomet
883 hedge funds and large institutions have $18.6B invested in Zimmer Biomet in 2020 Q1 according to their latest regulatory filings, with 70 funds opening new positions, 309 increasing their positions, 328 reducing their positions, and 163 closing their positions.
0.26% more ownership
Funds ownership: 88.79% → 89.06% (+0.26%)
6% less repeat investments, than reductions
Existing positions increased: 309 | Existing positions reduced: 328
7% less call options, than puts
Call options by funds: $43.9M | Put options by funds: $47M
11% less funds holding
Funds holding: 990 → 883 (-107)
32% less capital invested
Capital invested by funds: $27.3B → $18.6B (-$8.7B)
40% less funds holding in top 10
Funds holding in top 10: 25 → 15 (-10)
57% less first-time investments, than exits
New positions opened: 70 | Existing positions closed: 163
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$1.06B |
| 2 |
American Century Companies
Kansas City,
Missouri
|
+$124M |
| 3 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$107M |
| 4 |
Renaissance Technologies
New York
|
+$68.8M |
| 5 |
JIC
Johnson Investment Counsel
Cincinnati,
Ohio
|
+$68.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$138M |
| 2 |
BlackRock
New York
|
-$131M |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$113M |
| 4 |
Boston Partners
Boston,
Massachusetts
|
-$104M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$99.2M |
ZBH Hedge Fund Activity: Q1 2020 in Review
883 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q1 2020, worth a combined $18.6B — down 32% from $27.3B a quarter earlier.
Sellers outnumbered buyers: 163 funds closed out of ZBH and 70 opened new positions — a net loss of 93 holders — while 328 trimmed existing stakes and 309 added.
The largest buyer was Capital Research Global Investors, opening a new position worth an estimated $1.06B. The largest seller was Jennison Associates, cutting an estimated $138M.
- 883 institutional investors held Zimmer Biomet (ZBH) as of Q1 2020, down from 990 in Q4 2019.
- Funds reported $18.6B of Zimmer Biomet stock for Q1 2020, down 32% quarter-over-quarter.
- 70 funds opened new Zimmer Biomet positions in Q1 2020 and 163 closed out, a net change of -93 holders.
- The largest Zimmer Biomet buyer in Q1 2020 was Capital Research Global Investors, an estimated $1.06B added.
- The largest Zimmer Biomet seller in Q1 2020 was Jennison Associates, an estimated $138M sold.
Based on aggregated 13F filings for Q1 2020.